Today’s enterprise IT organizations are experiencing a massive upheaval due to pressure from employee forces. It’s a familiar story. Just think of the turmoil caused by the dawning of the bring-your-own-device (BYOD) era, with employees demanding to use their beloved personal mobile phones for work.
Hitachi Vantara’s latest improvements to Pentaho make it significantly easier for organizations to move data workloads from on premises to the cloud and back again. The new Pentaho 9.3 Long-Term Support (LTS), part of Hitachi’s Lumada portfolio, offers a cloud deployment option that we anticipate will be a critical accelerant of data-driven transformation.
The skyrocketing value of data has created a global supply and demand for data, data applications, and data services. This new data economy is powered by technologies that enable data access and sharing, including cloud platforms, exchanges, and marketplaces.
In the exponentially growing data warehousing space, it is very important to capture, process and analyze the metadata and metrics of the jobs/queries for the purposes of auditing, tracking, performance tuning, capacity planning, etc. Historically, on-premise (on-prem) legacy data warehouse solutions have mature methods of collecting and reporting performance insights via query log reports, workload repositories etc. However all of this comes with an overhead of cost-storage & cpu.
So, you’re working for a medium to large enterprise that uses Microsoft Dynamics 365 Finance & Supply Chain (D365 F&SCM) as its ERP system. You have multiple options for reporting and analysis available to you from Microsoft. But if your business is growing, you are probably looking to push beyond the out-of-the-box capabilities to develop your own custom analysis and meaningful data insights.
The end goal of clinical technology organizations in the US and abroad is to use modern technology to bring life-saving new treatments to fruition. Leaders in this sphere help generate the evidence and insights to help biotech, pharmaceutical, medical device, and diagnostic companies accelerate value, minimize risk, and optimize outcomes. Life sciences clients recognize that technology is the answer to inefficiencies and delays in delivering new treatments to the public.
The term “observability” means many things to many people. A lot of energy has been spent—particularly among vendors offering an observability solution—in trying to define what the term means in one context or another. But instead of getting bogged down in the “what” of observability, I think it’s more valuable to address the “why.” What are we trying to accomplish with observability? What is the end goal?
